NanoSphere Health Sciences Inc. (CSE:NSHS, OTC:NSHSF) (“Nanosphere” or “the Company”) wishes to provide an update regarding its operations in Canada, along with its Canadian partner, Delta 9 Cannabis Inc, (TSX:DN) (“Delta 9”).

We are pleased to announce that Delta 9 has filed a Notice of New Cannabis Product Application with Health Canada and will be proceeding to produce commercial batches of an ingestible cannabis oil using Nanosphere patented technology. Once produced, the initial commercial batches will require final review and approval by Delta 9 and Health Canada prior to being sold under the Delta 9 – Evolve brand in the Canadian Market.


Per NanoSphere Health Sciences CEO, Dr. Mark Percival: “This marks an important phase in our company’s development and our entry into the Canadian Market. It also marks the beginning for Canadian consumers who are looking to expand on the benefits they have experienced using cannabis products. The new products being launched by Delta 9 are the first in Canada to utilize aspects of our patented NanoSphere Delivery System. Medical cannabis patients and seasoned recreational users alike will appreciate the difference more effective delivery makes to their experiences”.

On behalf of the Board

Dr. Mark Percival, CEO

E-mail: mpercival@nanospherehealth.com

Investor Contact:

Victor Goncalves, Executive Vice President

Mobile: 204-997-5517

E-mail: vgoncalves@nanospherehealth.com

About NanoSphere Health Sciences Inc.

NanoSphere Health Sciences is a nanobiotechnology firm specializing in proprietary delivery systems for therapeutic agents. Our patented technology transforms our strategic partners good products into great products, further differentiating them in their respective markets.

For more information on NanoSphere, please visit: www.NanoSphereHealth.com

About Evolve Formulas

Evolve branded products are produced under license by leading manufacturers utilizing the proprietary, patented NanoSphere Delivery System™ of NanoSphere Health Sciences Inc.

For more information on Evolve Formulas, please visit www.EvolveFormulas.com

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Forward Looking Statement Caution

This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company’s intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company’s future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Without limitation, these include assumptions, risks and uncertainties inherent in completing sub-licensing arrangements in the United States, Canada and abroad, product demand, production, competition and government regulation of the Cannabis industry, any and all of which may have an adverse effect on the Company’s expansion plans, sales, revenues and its financial results and condition. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.

Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an Investor Presentation.

Source

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less